BLACK WEEKSFrascos −15% · kits −10% · resto −5%com o códigoEnvio grátis na Alemanha a partir de 200 €

Esta página foi traduzida automaticamente e pode conter erros. É falante nativo? Agradecemos o seu feedback e as suas correções.Enviar feedback

The Peptide Desk The Peptide Desk
Telmisartan, foto do produto

Relatório laboratorial

PDF
Testado
Testado
Telmisartan 40mg × 100 Tabs
Laboratório
Analiza Białek
Data
October 2026
Resultado
39.80 mg per tablet (40 mg label)
N.º da encomenda
Palavra-passe

Testado de forma independente, verificável com a palavra-passe diretamente no laboratório.

Medication

Telmisartan

Medication

Encomenda

Preço unitário - Envio grátis na Alemanha a partir de 200 € durante as Black Weeks
  • DHL com seguimento
  • Embalagem discreta

4.6 de 5 no Trustpilot73 avaliações

Num relance

Telmisartan em números

Os valores-chave da nossa enciclopédia. Arraste o ponto ao longo da curva para ver quanto resta após uma dose, segundo o cálculo.

Entrada completa da enciclopédia

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~24 hours

Half-life ~24 hours
After 48 hours: 25 %
Hour 2450 %Hour 4825 %Hour 7212.5 %Hour 1203.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

Approximately24hours

Class
Angiotensin II receptor antagonistARB
Use
Blood pressure controlcardiovascular protection
Sizes
40 to 80 mg2 sizes in the shop

Conhecimento

Tudo sobre Telmisartan

Informação detalhada disponível em breve.

Dosagem

A carregar informação de dosagem …

Mais na enciclopédia

FAQ

Perguntas frequentes

Fontes de cada resposta: entrada da enciclopédia

Ainda tem alguma pergunta?

Escreva-nos, a nossa equipa ajuda.

Is telmisartan approved?

Yes. ChEMBL lists telmisartan with phase 4 as the highest phase and first approval in 1998. ClinicalTrials.gov lists 349 trials with telmisartan, as of 26 October 2026.

What did ONTARGET show?

25,620 patients with vascular disease or high-risk diabetes received ramipril, telmisartan or both. After about 56 months the primary outcome was 16.5, 16.7 and 16.3 percent. Telmisartan was equivalent, the combination brought no benefit but more side effects.

And if an ACE inhibitor is not tolerated?

TRANSCEND tested this in 5,926 patients against placebo. The primary outcome was not significantly less common at 15.7 versus 17.0 percent. Cardiovascular death, heart attack or stroke occurred in 13.0 versus 14.8 percent, also not significant after correction.

Why less cough than with ACE inhibitors?

According to ChEMBL telmisartan blocks the AT1 receptor and not the enzyme ACE. In ONTARGET 1.1 percent had cough with telmisartan, 4.2 percent with ramipril. Angioedema occurred in 0.1 versus 0.3 percent.

What was measured in heart failure with weak kidneys?

In a small open trial with 107 patients kidney function worsened less often than with enalapril after 3 months (6.4 versus 22.9 percent). Hospital stays for heart failure were less common (34.1 versus 55.3 percent), there were 5 deaths in each group.

What do the trials on insulin and combinations show?

In 70 patients with diabetes and high blood pressure HOMA-IR fell to 1.79 after 12 weeks instead of 3.45 with other blood pressure drugs. A meta-analysis of 3 trials found stronger blood pressure lowering with amlodipine and better LDL values with rosuvastatin, tolerability was similar.

Relacionados

Produtos relacionados